SMT201300038B - Formulazione di paracetamolo iniettabile stabile epronto per l'uso - Google Patents

Formulazione di paracetamolo iniettabile stabile epronto per l'uso

Info

Publication number
SMT201300038B
SMT201300038B SM201300038T SM201300038T SMT201300038B SM T201300038 B SMT201300038 B SM T201300038B SM 201300038 T SM201300038 T SM 201300038T SM 201300038 T SM201300038 T SM 201300038T SM T201300038 B SMT201300038 B SM T201300038B
Authority
SM
San Marino
Prior art keywords
ready
stable injectable
paracetamol formulation
injectable paracetamol
formulation
Prior art date
Application number
SM201300038T
Other languages
English (en)
Italian (it)
Inventor
Ioulia Tseti
Original Assignee
Ioulia Tseti
Uni Pharma Kleon Tsetis Pharmaceutical Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ioulia Tseti, Uni Pharma Kleon Tsetis Pharmaceutical Lab filed Critical Ioulia Tseti
Publication of SMT201300038B publication Critical patent/SMT201300038B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SM201300038T 2010-05-19 2013-04-03 Formulazione di paracetamolo iniettabile stabile epronto per l'uso SMT201300038B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10005258A EP2389923B1 (fr) 2010-05-19 2010-05-19 Formule de paracétamol injectable, stable et prête à utiliser
PCT/EP2011/002482 WO2011144335A1 (fr) 2010-05-19 2011-05-18 Préparation de paracétamol injectable stable, prête à l'emploi

Publications (1)

Publication Number Publication Date
SMT201300038B true SMT201300038B (it) 2013-07-09

Family

ID=42338244

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201300038T SMT201300038B (it) 2010-05-19 2013-04-03 Formulazione di paracetamolo iniettabile stabile epronto per l'uso

Country Status (22)

Country Link
US (1) US8877817B2 (fr)
EP (1) EP2389923B1 (fr)
CN (1) CN102985069B (fr)
AP (1) AP3151A (fr)
BR (1) BR112012029212A2 (fr)
CA (1) CA2799666C (fr)
CY (1) CY1113999T1 (fr)
DK (1) DK2389923T3 (fr)
ES (1) ES2403121T3 (fr)
HK (1) HK1182315A1 (fr)
HR (1) HRP20130184T1 (fr)
MA (1) MA34314B1 (fr)
MY (1) MY160458A (fr)
PL (1) PL2389923T3 (fr)
PT (1) PT2389923E (fr)
RU (1) RU2519764C1 (fr)
SI (1) SI2389923T1 (fr)
SM (1) SMT201300038B (fr)
TN (1) TN2012000516A1 (fr)
UA (1) UA104381C2 (fr)
WO (1) WO2011144335A1 (fr)
ZA (1) ZA201208605B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA201300398B (en) * 2012-11-27 2013-09-25 Genfarma Laboratories S L Injectable liquid formulation of the combination of tramadol and paracetamol
WO2016008546A1 (fr) * 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Formulation aqueuse comprenant du paracétamol et de l'ibuprofène
CN105797166A (zh) * 2016-03-30 2016-07-27 吉林长白山药业集团股份有限公司 用羟丙基环糊精包合对乙酰氨基酚制成液体制剂的方法
WO2018192664A1 (fr) 2017-04-20 2018-10-25 Hyloris Developments Sa Procédé de préparation d'une composition à faible teneur en oxygène dissous, comprenant de l'acétaminophène, et éventuellement un ou plusieurs ains, et une composition obtenue à partir de celui-ci
WO2019180072A1 (fr) 2018-03-22 2019-09-26 Bayer Pharma Aktiengesellschaft Composition pharmaceutique parentérale consistant en du bialanate de néladénoson
WO2021222835A1 (fr) * 2020-04-30 2021-11-04 Purser Danny C Compositions et méthodes comprenant du glutathion réduit stable
GR1010637B (el) * 2023-01-13 2024-02-15 Ιουλια Κλεωνος Τσετη Σταθερο υδατικο διαλυμα παρακεταμολης για χρηση σε ενδοφλεβια εγχυση

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH648371A5 (de) 1982-01-29 1985-03-15 Fischer Ag Georg Anschlusseinrichtung fuer armaturen.
US4727064A (en) 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
FR2751875B1 (fr) 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
JP2001233787A (ja) * 2000-02-04 2001-08-28 Patents Exploitation Co Bv 小・中サイズのペプチド含有薬学的組成物
US20040045546A1 (en) * 2002-09-05 2004-03-11 Peirce Management, Llc Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
FR2851164B1 (fr) * 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
US9399012B2 (en) * 2007-11-13 2016-07-26 Mallinckrodt Ip Reduced dose intravenous acetaminophen
EP2307056B1 (fr) * 2008-01-17 2021-12-15 Pharmis Biofarmacêutica, LDA Compositions pharmaceutiques aqueuses stables contenant du paracetamol
US20090246276A1 (en) * 2008-01-28 2009-10-01 Graham Jackson Pharmaceutical Compositions
CN102488716B (zh) * 2008-02-29 2013-09-11 株式会社明治 丙酸杆菌发酵物在制造皮肤粗糙预防、改善剂中的应用

Also Published As

Publication number Publication date
MA34314B1 (fr) 2013-06-01
ES2403121T3 (es) 2013-05-14
CN102985069B (zh) 2014-11-26
CY1113999T1 (el) 2016-07-27
UA104381C2 (uk) 2014-01-27
SI2389923T1 (sl) 2013-06-28
DK2389923T3 (da) 2013-03-18
HRP20130184T1 (hr) 2013-05-31
AP2012006597A0 (en) 2012-12-31
CN102985069A (zh) 2013-03-20
PT2389923E (pt) 2013-03-28
EP2389923A1 (fr) 2011-11-30
HK1182315A1 (en) 2013-11-29
US8877817B2 (en) 2014-11-04
ZA201208605B (en) 2013-09-25
RU2519764C1 (ru) 2014-06-20
MY160458A (en) 2017-03-15
WO2011144335A1 (fr) 2011-11-24
TN2012000516A1 (en) 2014-04-01
AP3151A (en) 2015-03-31
CA2799666A1 (fr) 2011-11-24
EP2389923B1 (fr) 2013-01-30
BR112012029212A2 (pt) 2020-09-29
PL2389923T3 (pl) 2013-06-28
WO2011144335A8 (fr) 2012-12-06
US20130210922A1 (en) 2013-08-15
CA2799666C (fr) 2016-02-16

Similar Documents

Publication Publication Date Title
BR112012013148A2 (pt) formulação farmacêutica e uso
SMT201500210B (it) Composizioni applicazioni di gel rimovibili per unghie e metodi per il loro uso
SMT201400181B (it) Composizioni per vasocostrizione e metodi d'uso
BR112013010988A2 (pt) composição fluída e uso
IL212922B (en) Stable liquid formulations containing anti-il-1beta antibody and syringes and self-injecting syringes containing them
SMT201300038B (it) Formulazione di paracetamolo iniettabile stabile epronto per l'uso
BR112013011448A2 (pt) composto, composição farnmacêutica, e, uso do composto
BRPI0822104A2 (pt) Composições antimicrobianas e métodos para o uso das mesmas
BR112014014547A2 (pt) compostos antagonistas de e-selectina, composições e métodos de uso
BR112013023174A2 (pt) "compostos derivados de triterpenoide de c4-monometila, composição farmacêutica compreendendo os referidos compostos e uso dos mesmos"
BR112013023681A2 (pt) compostos de álcool propargílico 6,5-heterocíclico e uso dos mesmos
BR112013008259A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112013015397A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112013006016A2 (pt) compostos de azabenzotiazol, composições e métodos de uso
IT1398930B1 (it) Formulazioni farmaceutiche bistrato contenenti agonisti ed antagonisti oppioidi.
BR112012012969A2 (pt) '' formulação farmacêutica líquida e uso de um antioxidante''
BR112012001797A2 (pt) composto bicíclico e uso do mesmo para propósitos médicos
BR112014010739A2 (pt) agentes terapêuticos e uso dos mesmos
CO6781486A2 (es) Compuestos y su uso
BR112012019473A2 (pt) compostos composição farmacêutica combinação de um composto uso de um composto e dispositivo
BR112013003530A2 (pt) ''produto farmacêutico, kit, uso e preparações''
BR112012030427A2 (pt) dispositivo de limpeza e uso do dispositivo de limpeza
BR112012031861A2 (pt) uso de 5a-androstano (alquil)-3b, 5, 6b-triol
BR112012031967A2 (pt) composto, uso de um composto, combinação de um composto e composição farmacêutica
SMT201500192B (it) Formulazione di paracetamolo iniettabile, stabile e pronta all'uso